Screener
AbCellera Biologics Inc. ABCL Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from AbCellera Biologics Inc.’s reported figures.
Based on trailing twelve months.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
FAQ
- What is AbCellera Biologics Inc.'s operating margin?
- AbCellera Biologics Inc. (ABCL) reported operating margin of -340.3% in Q2 2026.
- How has AbCellera Biologics Inc.'s operating margin changed year-over-year?
- AbCellera Biologics Inc.'s operating margin increased by 59.9% year-over-year, from -847.6% to -340.3%.
- What is the long-term trend for AbCellera Biologics Inc.'s operating margin?
- Over 4 years (2020 to 2025), AbCellera Biologics Inc.'s operating margin has grown at a 44.2% compound annual growth rate (CAGR), from 66.9% to -289%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about AbCellera Biologics Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude